NASDAQ:COSM Cosmos Health Q1 2025 Earnings Results & Report $0.34 +0.02 (+6.84%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$0.33 0.00 (-1.16%) As of 10/9/2026 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Cosmos Health reported Q1 2025 earnings on May 15, 2025. The company reported EPS of $0.01. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2025Report DateMay 15, 2025TimeBefore Market Opens Cosmos Health EPS ResultsActual EPS$0.01Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate2 of last 6 quartersCosmos Health Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsCosmos Health's next earnings date is estimated for Friday, November 13, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Cosmos Health Q1 2025 Earnings FAQ Did Cosmos Health beat earnings estimates for Q1 2025? Cosmos Health (NASDAQ:COSM) reported earnings of $0.01 per share for Q1 2025. The report was announced on Thursday, May 15, 2025. When is Cosmos Health's next earnings date? Cosmos Health's next earnings date is estimated for Friday, November 13, 2026. MarketBeat tracks confirmed and estimated earnings dates for Cosmos Health on the company's earnings history page. Cosmos Health Earnings HeadlinesCosmos Health Inc. Reaffirms Revenue Guidance for Fiscal 202658 minutes ago | marketscreener.comMCosmos Health Inc. Announces Preliminary Revenue Results for the Third Quarter and Nine Months Ended September 30, 2026October 10 at 8:28 AM | marketscreener.comMFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.October 10 at 1:00 AM | Stansberry Research (Ad)Comparing Amplifon (OTCMKTS:AMFPF) & Cosmos Health (NASDAQ:COSM)October 7 at 6:15 AM | americanbankingnews.comGuardant Health, Inc. Announces Cosmos-Mel01 Study Results for Guardant Reveal Liquid Biopsy Test in Resected MelanomaOctober 6, 2026 | marketscreener.comMCosmos Health’s Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 BillionOctober 1, 2026 | usatoday.comSee More Cosmos Health Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cosmos Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cosmos Health and other key companies, straight to your email. Email Address About Cosmos HealthCosmos Health (NASDAQ:COSM) is a global healthcare group that develops, markets and distributes pharmaceutical, nutraceutical and wellness products. The company serves consumers, healthcare professionals and commercial partners through a portfolio that includes prescription and over-the-counter medicines, dietary supplements, vitamins and other health-related products. Cosmos Health markets proprietary nutraceutical brands, including Sky Premium Life, and offers products across categories such as vitamins, minerals, sports nutrition and general wellness. Through its pharmaceutical activities, the company is also involved in the wholesale distribution of medicines, medical products and related healthcare items. Founded in 2009 and formerly known as Cosmos Holdings Inc., the company is headquartered in Chicago and has operations and business relationships spanning the United States, Europe and other international markets. Its European activities have included pharmaceutical distribution and manufacturing partnerships, particularly in Greece. Cosmos Health is led by Chief Executive Officer Greg Siokos, who co-founded the company.View Cosmos Health ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
